Gossamer Bio, Inc. (GOSS)
NASDAQ: GOSS · Real-Time Price · USD
9.28
-0.03 (-0.32%)
At close: Oct 12, 2026, 4:00 PM EDT
9.94
+0.66 (7.11%)
Pre-market: Oct 13, 2026, 9:18 AM EDT
Gossamer Bio Stock Forecast
GOSS's stock price has decreased by -94.91% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
According to 7 analysts polled by S&P Global, Gossamer Bio stock has a consensus rating of "Buy" and an average price target of $82.48. The average 1-year stock price forecast is 788.79% higher than the current stock price, while the lowest is $22.4 (+141.38%) and the highest is $120 (+1,193.10%).
Price Target: $82.48 (+788.79%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Gossamer Bio stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 | Sep '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 1 | 1 | 2 | 2 | 2 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 5 | 4 | 4 | 3 | 3 | 3 |
| Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 9 | 7 | 7 | 7 | 7 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
Unknown Analyst Guggenheim No rating | Guggenheim | Hold Maintains n/a | Hold | Maintains | n/a | n/a | Sep 24, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $90 | Buy | Reiterates | $90 | +869.83% | Sep 21, 2026 |
| Wedbush | Wedbush | Hold Maintains $80 | Hold | Maintains | $80 | +762.07% | Aug 14, 2026 |
| Barclays | Barclays | Sell Maintains $22 | Sell | Maintains | $22 | +141.38% | Jul 28, 2026 |
| Leerink Partners | Leerink Partners | Buy Upgrades $80 | Buy | Upgrades | $80 | +762.07% | Jul 27, 2026 |
Financial Forecast
Revenue This Year
35.86M
from 48.47M
Decreased by -26.02%
Revenue Next Year
16.75M
from 35.86M
Decreased by -53.29%
EPS This Year
-18.01
from -60.00
EPS Next Year
-15.61
from -18.01
EPS and Forward PE are based on non-GAAP adjusted numbers.